S.Res. 235Senate117th Congress (2021-2023)Passed Congress

A resolution designating May 15, 2021, as "National MPS Awareness Day".

Introduced May 25, 2021

AI-Generated Summary

Updated February 8, 2026 at 3:30 AM UTC

The resolution designates May 15, 2021, as National MPS Awareness Day to raise public and medical community awareness of mucopolysaccharidosis (MPS), a group of rare genetic disorders. It aims to promote early detection, research, and support for individuals affected by MPS.

Key Provisions

  • Designates May 15, 2021 as National MPS Awareness Day.
  • Expresses Senate support for the goals and ideals of National MPS Awareness Day.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateFloor Latest Action

Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3460; text: CR S3428)

May 25, 2021

View full timeline
SenateIntro Referral

Introduced in Senate

May 25, 2021

SenateFloor

Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3460; text: CR S3428)

May 25, 2021

Floor Debate

1 member

What members said about S.Res. 235 on the floor

1 Democrat
Charles E. Schumer
Sen. Charles E. SchumerD-NY · May 25, 2021

Madam President, I ask unanimous consent that the Senate proceed to the consideration of S. Res. 235 submitted earlier today. Madam President, I ask unanimous consent that the resolution be agreed…

Bill Text

Latest available legislative text

Reading Mode
Latest
Agreed to SenateIssued May 25, 2021

III

117th CONGRESS

1st Session

S. RES. 235

IN THE SENATE OF THE UNITED STATES

May 25, 2021

Mr. Bennet (for himself and Mr. Graham) submitted the following resolution; which was considered and agreed to

RESOLUTION

Designating May 15, 2021, as National MPS Awareness Day.

Whereas mucopolysaccharidosis (referred to in this preamble as MPS) are a group of genetically determined lysosomal storage diseases that render the human body incapable of producing certain enzymes needed to break down complex carbohydrates;

Whereas MPS diseases cause complex carbohydrates to be stored in almost every cell in the body, which progressively leads to cellular damage;

Whereas the cellular damage caused by MPS—

(1)

adversely affects the human body by damaging the heart, lungs, bones, central nervous system, and other internal organs; and

(2)

often results in intellectual disabilities, short stature, corneal damage, joint stiffness, loss of mobility, speech and hearing impairment, heart disease, hyperactivity, chronic respiratory problems, and, most painfully, a drastically shortened life span;

Whereas symptoms of MPS are usually not apparent at birth;

Whereas, without treatment, the life expectancy of an individual afflicted with MPS begins to decrease at a very early stage in the life of that individual;

Whereas research has resulted in the development of limited treatments for some MPS diseases;

Whereas, as of the date of adoption of this resolution, promising advancements in the pursuit of treatments for additional MPS diseases are underway;

Whereas, despite the creation of new remedies, the blood-brain barrier continues to be a significant impediment to effectively treating the brain, which prevents the treatment of many of the symptoms of MPS;

Whereas the quality of life of individuals afflicted with MPS and the treatments available to those individuals will be enhanced through the development of early detection and early intervention techniques;

Whereas treatments for and research advancements relating to MPS are limited by a lack of awareness about MPS diseases;

Whereas the lack of awareness about MPS diseases extends to individuals within the medical community;

Whereas the cellular damage caused by MPS makes MPS a model for the study of many other degenerative genetic diseases; and

Whereas the development of effective therapies and a potential cure for MPS diseases can be accomplished by increased awareness, research, data collection, and information distribution: Now, therefore, be it

That the Senate—

(1)

designates May 15, 2021, as National MPS Awareness Day; and

(2)

supports the goals and ideals of National MPS Awareness Day.